Clinical outcomes of ultrasound-guided mammotome vacuum-assisted excision for benign breast tumors and its impact on serum tumor markers
Mammotome<sup>®</sup> VAE achieved high technical success, low morbidity, excellent cosmesis, and no increase in serum CA15-3, CEA, or CA125 through 3 months. Twelve-month local control was favorable. Longer follow-up and multicenter studies with broader biologic measures are needed to confirm long-term systemic neutrality and external validity.
Authors
- Lixing Zou
- Qiong Sun
- Rong Liu (ORCID: https://orcid.org/0009-0005-4234-1393)
- Hua Chen (ORCID: https://orcid.org/0000-0002-0641-2837)
- Chang Zhou (ORCID: https://orcid.org/0000-0002-6029-1132)
- Yong He (ORCID: https://orcid.org/0009-0002-2362-6180)
Institutions
- Second Hospital of Yichang (CN)
- Yichang Central People's Hospital (CN)
Publication Details
- Journal
- BMC Surgery
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1186/s12893-025-03293-x
- Primary Topic
- Breast Lesions and Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00